These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9245491

  • 21. Suppression of lymphocyte interleukin-2 receptor expression by glucocorticoids, cyclosporine, or both.
    Briggs WA, Gao ZH, Xing JJ, Gimenez LF, Samaniego MD, Scheel PJ, Choi MJ, Burdick JF.
    J Clin Pharmacol; 1996 Oct; 36(10):931-7. PubMed ID: 8930780
    [Abstract] [Full Text] [Related]

  • 22. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S, Kierszenbaum F.
    J Immunol; 1996 May 15; 156(10):3866-74. PubMed ID: 8621925
    [Abstract] [Full Text] [Related]

  • 23. Profibrotic cytokines and lymphocyte proliferation in stable renal allograft recipients treated with or without cyclosporine A.
    Waiser J, Schneider M, Eljazyfer S, Slowinski T, Glander P, Einecke G, Budde K, Neumayer HH, Böhler T.
    Clin Immunol; 2006 Apr 15; 119(1):59-66. PubMed ID: 16451828
    [Abstract] [Full Text] [Related]

  • 24. Immunosuppressive efficacy of tetrandrine combined with methylprednisolone against mitogen-activated peripheral blood mononuclear cells of haemodialysis patients.
    Xu W, Meng K, Kusano J, Matsuda H, Hara Y, Fujii Y, Suzuki S, Ando E, Wang X, Tu Y, Tanaka S, Sugiyama K, Yamada H, Hirano T.
    Clin Exp Pharmacol Physiol; 2017 Sep 15; 44(9):924-931. PubMed ID: 28613399
    [Abstract] [Full Text] [Related]

  • 25. Clinical impact of cyclosporine cellular pharmacodynamics in minimal change nephrotic syndrome.
    Hirano T, Akashi T, Keira T, Oka K, Ihoya N, Yoshida M.
    Clin Pharmacol Ther; 2000 Nov 15; 68(5):532-40. PubMed ID: 11103756
    [Abstract] [Full Text] [Related]

  • 26. Trypanosomal immunosuppressive factor: a secretion product(s) of Trypanosoma cruzi that inhibits proliferation and IL-2 receptor expression by activated human peripheral blood mononuclear cells.
    Kierszenbaum F, Cuna WR, Beltz LA, Sztein MB.
    J Immunol; 1990 May 15; 144(10):4000-4. PubMed ID: 2185317
    [Abstract] [Full Text] [Related]

  • 27. [Effects of lovastatin combined with cyclosporine A on cultured human peripheral blood mononuclear cells proliferation, cytokines expression and cytotoxicity].
    Li CH, Li XW, Li H, Duan L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec 15; 23(6):614-8. PubMed ID: 12901109
    [Abstract] [Full Text] [Related]

  • 28. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus.
    Lee HT, Chen WS, Sun KH, Chou CT, Tsai CY.
    J Rheumatol; 2009 Sep 15; 36(9):1910-6. PubMed ID: 19605669
    [Abstract] [Full Text] [Related]

  • 29. Immunological studies in uremic and kidney transplanted patients.
    Langhoff E.
    Dan Med Bull; 1989 Apr 15; 36(2):160-75. PubMed ID: 2651030
    [Abstract] [Full Text] [Related]

  • 30. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH, Yan Y, De Boer B, Bishop GA, House AK.
    Transplantation; 2003 Feb 15; 75(3):368-74. PubMed ID: 12589161
    [Abstract] [Full Text] [Related]

  • 31. Pentoxifylline potentiates in vitro lymphocyte suppression by glucocorticoids and immunosuppressive drugs.
    Briggs WA, Eustace J, Mathew S, Gimenez LF, Choi M, Scheel PJ, Burdick J.
    J Clin Pharmacol; 1998 Jun 15; 38(6):561-6. PubMed ID: 9650547
    [Abstract] [Full Text] [Related]

  • 32. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
    Briggs WA, Gao ZH, Xing JJ, Scheel PJ, Gimenez LF, Burdick JF.
    Transplant Proc; 1996 Aug 15; 28(4):2063-5. PubMed ID: 8769157
    [No Abstract] [Full Text] [Related]

  • 33. Effects of glucocorticoids and cyclosporine on IL-2 and I kappa B alpha mRNA expression in human peripheral blood mononuclear cells.
    Briggs WA, Han SH, Miyakawa H, Burdick JF, Kwon HM.
    J Clin Pharmacol; 1999 Feb 15; 39(2):119-24. PubMed ID: 11563402
    [Abstract] [Full Text] [Related]

  • 34. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 15; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 35. The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients.
    Sliwinska-Stanczyk P, Pazdur J, Ziolkowska M, Jaworski J, Kaminska-Tchorzewska E, Lacki JK.
    Scand J Rheumatol; 2007 Jan 15; 36(3):167-71. PubMed ID: 17657668
    [Abstract] [Full Text] [Related]

  • 36. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
    Wright DC, Deol HS, Tuch BE.
    Transpl Immunol; 1999 Sep 15; 7(3):141-7. PubMed ID: 10608297
    [Abstract] [Full Text] [Related]

  • 37. Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
    Tanaka S, Nakajima K, Hirano T, Oka K, Saito T, Wakata N.
    J Pharm Pharmacol; 2008 Oct 15; 60(10):1341-6. PubMed ID: 18812027
    [Abstract] [Full Text] [Related]

  • 38. Strong additive effect of calcitriol and cyclosporine A on lymphocyte proliferation in vitro and rat liver allotransplantations in vivo.
    Zhang AB, Zheng SS.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2090-5. PubMed ID: 17199961
    [Abstract] [Full Text] [Related]

  • 39. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov 20; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 40. Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells.
    Horigome A, Hirano T, Oka K, Takeuchi H, Sakurai E, Kozaki K, Matsuno N, Nagao T, Kozaki M.
    Immunopharmacology; 1997 Aug 20; 37(1):87-94. PubMed ID: 9285247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.